Theresa Hahn

12PUBLICATIONS
69CO-AUTHORS
Gene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursRehabilitationNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 03, 2026
TA-TMA and GVHD are distinct consequences of endothelial injury: a MIDAS consortium study.

|Jan 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|Nov 14, 2025
Risk Factors beyond Chemotherapy Exposure for Secondary Myeloid Neoplasms after Hematologic Cancers: A SEER-Based Study.

Abhay Singh, Theresa Hahn, Rahul Mishra

|Sep 18, 2025
ICANS and mortality after CAR-T therapy for NHL patients can be predicted using physical function measures of falls, balance and strength deficits, and use of an assistive device.

Nisha M Nair, Theresa E Hahn, Hillary Jacobson

|Apr 29, 2025
High incidence of severe TA-TMA increases mortality in adult allogeneic transplant recipients: a prospective MIDAS Consortium study.

Sumithira Vasu, Qiuhong Zhao, Elizabeth Greer Miller

|May 03, 2024
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival.

Marcelo C Pasquini, Paul K Wallace, Brent Logan

Pageof 2

Frequent Collaborators

3 joint publications

Heather J Cordell

3 joint publications

Megan M Herr

3 joint publications

Wei-Yu Lin

3 joint publications

Claire Elstob